Diversion of prostaglandin endoperoxide metabolism by selective inhibition of thromboxane A2 biosynthesis in lung, spleen or platelets
References (35)
- et al.
Arterial walls generate from prostaglandin endoperoxides a substance which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation
Prostaglandins
(1976) - et al.
Prostacyclin (PGX) is the endogenous metabolite responsible for relaxation of coronary arteries induced by arachidonic acid
Prostaglandins
(1977) - et al.
The importance of phospholipase A2 in prostaglandin biosynthesis
Biochem. Pharmacol.
(1976) - et al.
Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides
Prostaglandins
(1976) - et al.
Polymorphonuclear leukocytes produce thromboxane A2-like activity during phagocytosis
Prostaglandins
(1976) - et al.
The chemical characterization of prostaglandin X (prostacyclin)
Prostaglandins
(1976) - et al.
N-0164 inhibits generation of thromboxane A2-like activity from prostaglandin endoperoxides by human platelet microsomes
Prostaglandins
(1976) - et al.
A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation
Prostaglandins
(1976) - et al.
Prostaglandin endoperoxides and thromboxane generating systems and their selective inhibition
Prostaglandins
(1976) - et al.
Human arterial and venous tissue generates prostacyclin (prostaglandin X) a potent inhibitor of platelet aggregation
Lancet
(1977)
A simple radiochemical assay for prostaglandin synthetase
Prostaglandins
(1974)
Endogenous formation of the prostaglandin endoperoxide metabolite thromboxane B2 by brain tissue
Biochem. Biophys. Res. Commun.
(1976)
The effects of prostaglandin endoperoxides and thromboxane A2 on strips of rabbit coeliac artery and certain other smooth muscle preparations
Brit. J. Pharmacol.
(1976)
Release of novel prostaglandins and thromboxane after immunological challenge of guinea pig lung
Nature (London)
(1976)
Coronary arterial smooth muscle contraction by a substance released from platelets; evidence it is thromboxane A2
Science
(1976)
Indomethacin and aspirin abolish prostaglandin release from the spleen
Nature New Biol.
(1971)
Some effects of inhibiting endogenous prostaglandin formation on the responses of the cat spleen
Brit. J. Pharmacol.
(1973)
Cited by (94)
Effect of the antenatal administration of celecoxib during the second and third trimesters of pregnancy on prostaglandin, cytokine, and nitric oxide levels in rabbits
2003, American Journal of Obstetrics and GynecologyRole of prostanoids and endothelins in the prevention of cyclosporine-induced nephrotoxicity
2001, Prostaglandins Leukotrienes and Essential Fatty AcidsEffects of OKY-046 and nifedipine in cyclosporine-induced renal dysfunction in rats
1996, Prostaglandins Leukotrienes and Essential Fatty AcidsTranscoronary platelet activation and consumption in coronary artery disease: Studies at rest
1988, Thrombosis ResearchU46619 and carbocyclic thromboxane A<inf>2</inf>-induced increases in tracheal mucous gel layer thickness
1988, Prostaglandins, Leukotrienes and Essential Fatty Acids
- †
Present address: Rudolf Magnus Institute for Pharmacology, University of Utrecht, Vondellaan 6, Utrecht, The Netherlands.
Copyright © 1977 Published by Elsevier B.V.